Merchant Accounts for Nutraceuticals and Dietary Supplements
Why supplements are high-risk, FDA/FTC exposure, continuity billing realities, and the underwriting criteria specific to nutra merchants.
Why supplements are high-risk, FDA/FTC exposure, continuity billing realities, and the underwriting criteria specific to nutra merchants.
Three drivers stack: (1) FDA/FTC enforcement risk on health claims, (2) high refund and dispute rates inherent to "try it" continuity offers, and (3) MCC 5122/5499 falling under enhanced acquirer monitoring. Even clean nutra brands run 1.5–3× the dispute rate of low-risk verticals.
Continuity is the most-disputed billing model in nutra. Acquirers expect:
Skip any of these and dispute ratios climb past 1% inside 60 days.
Nutra rates land in 3.95%–5.95% + $0.25, lower than peptides because the regulatory profile is cleaner. Rolling reserve: 5–10% held 180 days. Continuity merchants get higher reserves than single-purchase. Monthly caps depend on processing history — new merchants start at $50K and step up.
Most established nutra brands run multiple MIDs across multiple acquirers — splitting volume reduces single-MID risk if one bank gets nervous about an FDA enforcement cycle. We help structure 2–3 MID setups for brands over $100K/month.
Stripe's policy prohibits "high-risk supplements" — interpreted broadly. Continuity nutra is a near-certain freeze. Even one-time nutra often gets terminated after a chargeback spike. Stripe's monitoring catches MCC drift and dispute-ratio changes weekly.
Join 4,200+ high-risk merchants processing with confidence. Apply now for a free, no-obligation soft review.